These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 8713794)
1. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794 [TBL] [Abstract][Full Text] [Related]
2. Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood. Watala C; Golański J; Boncler MA; Pietrucha T; Gwoździński K Platelets; 1998; 9(5):315-27. PubMed ID: 16793756 [TBL] [Abstract][Full Text] [Related]
3. Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Winocour PD; Watala C; Perry DW; Kinlough-Rathbone RL Thromb Haemost; 1992 Nov; 68(5):577-82. PubMed ID: 1455404 [TBL] [Abstract][Full Text] [Related]
4. Reduced membrane fluidity and increased glycation of membrane proteins of platelets from diabetic subjects are not associated with increased platelet adherence to glycated collagen. Winocour PD; Watala C; Kinlough-Rathbone RL J Lab Clin Med; 1992 Dec; 120(6):921-8. PubMed ID: 1453113 [TBL] [Abstract][Full Text] [Related]
5. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes. Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779 [TBL] [Abstract][Full Text] [Related]
6. Response of human blood platelet membrane to sodium selenite. Zbikowska HM; Gwoździński K; Wachowicz W; Krajewski T J Physiol Pharmacol; 1999 Sep; 50(3):455-62. PubMed ID: 10574474 [TBL] [Abstract][Full Text] [Related]
7. Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin α(IIb)β(3) and PADGEM-140 in membranes of platelets from diabetic juveniles? Watala C; Golański J; Walkowiak B; Baj Z; Pietrucha T; Tchórzewski H; Bodalski J; Ciemiewski CS Platelets; 1996; 7(3):173-80. PubMed ID: 21043597 [TBL] [Abstract][Full Text] [Related]
8. Microenvironmental changes in platelet membranes induced by the interaction of fibrinogen-derived peptide ligands with platelet integrins. Watala C; Gwoźdiński K; Pluskota E; Dzieciatkowska E; Cierniewski CS Eur J Biochem; 1996 Jan; 235(1-2):281-8. PubMed ID: 8631343 [TBL] [Abstract][Full Text] [Related]
9. [Role of nonenzymatic glycosylation of proteins in disorders of erythrocytes and blood platelets in diabetes mellitus]. Watała C Acta Haematol Pol; 1993; 24(2):95-101. PubMed ID: 8372620 [TBL] [Abstract][Full Text] [Related]
10. Cytosolic Ca2+ content and membrane fluidity of platelets and polymorphonuclear leucocytes in diabetes mellitus. Caimi G; Lo Presti R; Canino B; Montana M; Ventimiglia G; Catania A; Sarno A Horm Metab Res; 1995 Aug; 27(8):352-5. PubMed ID: 7590622 [TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? Watala C; Boncler M; Pietrucha T; Trojanowski Z Platelets; 1999; 10(1):52-60. PubMed ID: 16801071 [TBL] [Abstract][Full Text] [Related]
12. A conformational model for the action of general anesthetics at the membrane level. II. Experimental observations on the effects of anesthetics on lipid fluidity and lipid protein interactions. Lenaz G; Mazzanti L; Curatola G; Bertoli E; Bigi A; Zolese G Ital J Biochem; 1978; 27(6):401-30. PubMed ID: 755801 [TBL] [Abstract][Full Text] [Related]
13. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation. Kamboj SS; Chopra K; Sandhir R Neuroscience; 2009 Aug; 162(2):349-58. PubMed ID: 19426784 [TBL] [Abstract][Full Text] [Related]
15. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Taffi R; Vignini A; Lanciotti C; Luconi R; Nanetti L; Mazzanti L; Provinciali L; Silvestrini M; Bartolini M Cephalalgia; 2005 May; 25(5):353-8. PubMed ID: 15839850 [TBL] [Abstract][Full Text] [Related]
16. The epidermal growth factor-like domain from tissue plasminogen activator. Cloning in E. coli, purification and ESR studies of its interaction with human blood platelets. Pietrucha T; Stec WJ; Okruszek A; Uznański B; Koziołkiewicz M; Wilk A; Płucienniczak A; Swiatkowska M; Cierniewski CS Acta Biochim Pol; 1994; 41(1):25-34. PubMed ID: 8030371 [TBL] [Abstract][Full Text] [Related]
17. Membrane fluidity of blood cells. Hollán S Haematologia (Budap); 1996; 27(3):109-27. PubMed ID: 14653448 [TBL] [Abstract][Full Text] [Related]
18. Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation. Simon CG; Gear AR Biochemistry; 1998 Feb; 37(7):2059-69. PubMed ID: 9485333 [TBL] [Abstract][Full Text] [Related]
19. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers. Hussain MA; Agnihotri A; Siedlecki CA Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412 [TBL] [Abstract][Full Text] [Related]